ALT
USDAltimmune Inc. Common Stock
$4.110+0.190 (4.847%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$3.920
最高
$4.160
最低
$3.775
交易量
2.59M
公司基本面
市值
428.8M
行業
生物科技
國家
United States
交易統計
平均交易量
2.84M
交易所
NGM
貨幣
USD
52週範圍
最低 $2.9當前 $4.110最高 $11.16
相關新聞
GlobeNewswire
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
Enrollment completed ahead of schedule, underscoring strong interest from patient community in a potential new therapeutic option On track to complete the 24-week treatment period and announce topline results in 2026
查看更多
Reuters
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera has become the obesity drug market's hottest ticket.
查看更多
GlobeNewswire
Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases,
查看更多
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。